Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 88

    Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

    Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

    Medical Dialogues Bureau31 Aug 2019 9:30 AM IST
    Alimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
    Dr Abhinay named as new CEO of KIMS Hospitals

    Dr Abhinay named as new CEO of KIMS Hospitals

    Medical Dialogues Bureau31 Aug 2019 9:00 AM IST
    In his previous role as Vice-President, Dr Abhinay oversaw Business Development and Strategy for KIMS Hospitals, a statement said.Hyderabad:...
    Glenmark Pharma gets USFDA nod for generic version of Elidel Cream to treat skin conditions

    Glenmark Pharma gets USFDA nod for generic version of Elidel Cream to treat skin conditions

    Farhat Nasim30 Aug 2019 3:26 PM IST
    The approved Pimecrolimus Cream is a generic version of Elidel Cream, 1 per cent, of Bausch Health US, LLC, Glenmark Pharma said.New Delhi: Glenmark...
    Lantech Pharma gets USFDA warning letter for deviations from CGMP at Andhra plant

    Lantech Pharma gets USFDA warning letter for deviations from CGMP at Andhra plant

    Medical Dialogues Bureau30 Aug 2019 10:00 AM IST
    "This warning letter summarises significant deviations from CGMP for active pharmaceutical ingredients (API)..because your methods, facilities, or...
    Granules India to sell entire stake in Granules OmniChem to JV Ajinomoto

    Granules India to sell entire stake in Granules OmniChem to JV Ajinomoto

    Medical Dialogues Bureau30 Aug 2019 9:45 AM IST
    GOC is an equal joint venture between Granules India and S A Ajinomoto Omnichem NV (now doing business as Ajinomoto Bio-Pharma Services), an...
    Medtronic CEO Omar Ishrak to step down in 2020, Geoff Martha to take over

    Medtronic CEO Omar Ishrak to step down in 2020, Geoff Martha to take over

    Medical Dialogues Bureau30 Aug 2019 9:17 AM IST
    Omar Ishrak, who will turn 65 next year, will continue to be the chairman of the board, the company said. Before joining Medtronic as CEO in 2011,...
    Roche Tecentriq wins European nod for breast cancer

    Roche Tecentriq wins European nod for breast cancer

    Medical Dialogues Bureau30 Aug 2019 9:15 AM IST
    The European Commission approved Tecentriq with Abraxane for people with metastatic triple-negative breast cancer that tests positive for a protein...
    Sterling Biotech case: ED records statement of Ahmed Patels son Faisal

    Sterling Biotech case: ED records statement of Ahmed Patel's son Faisal

    Medical Dialogues Bureau29 Aug 2019 4:57 PM IST
    NEW DELHI: The ED has recorded the statement of Faisal Patel, son of senior Congress leader Ahmed Patel, in connection with its probe into the alleged...
    USFDA grants orphan drug status to AstraZenecas asthma drug Fasenra

    USFDA grants orphan drug status to AstraZeneca's asthma drug Fasenra

    Medical Dialogues Bureau29 Aug 2019 3:57 PM IST
    AstraZeneca said on Wednesday that the U.S. Food and Drug Administration has granted orphan drug status to its severe asthma drug, Fasenra, to treat...
    Brand-name drug prices rising at slower pace, lower amounts: AP Analysis

    Brand-name drug prices rising at slower pace, lower amounts: AP Analysis

    Medical Dialogues Bureau29 Aug 2019 3:32 PM IST
    After years of frequent list price hikes, many drugmakers are showing some restraint, according to the analysis of drug prices provided by health...
    FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

    FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

    Medical Dialogues Bureau29 Aug 2019 9:35 AM IST
    The U.S. Food and Drug Administration said on Wednesday it had identified 63 cases of worsening liver function in certain patients taking hepatitis C...
    Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

    Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

    Medical Dialogues Bureau29 Aug 2019 9:25 AM IST
    OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company...
    PrevNext

    Popular Stories

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

    Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok